Retrieve available abstracts of 7 articles: HTML format
Single Articles
June 2025
LIN YH, Chen MH, Yu SC, Bai YM, et al Risk of Alzheimer Disease and Vascular Dementia in Patients With Peripheral
Vestibular Disorders: A Longitudinal Study of 140,726 Participants.
J Clin Psychiatry. 2025;86:24m15699. PubMedAbstract available
April 2025
PRICE MZ, Small GW Benefits and Risks of New Tests for Alzheimer's Disease.
J Clin Psychiatry. 2025;86:25com15837. PubMed
November 2024
JAIN R, Chepke C, Davis LL, McIntyre RS, et al Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating
Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and
Posttraumatic Stress Disorder.
J Clin Psychiatry. 2024;85:plunaro2417ah. PubMedAbstract available
August 2023
ANDRADE C How to Use Percentiles to Better Understand Standardized Mean Difference (SMD) as
a Measure of Effect Size.
J Clin Psychiatry. 2023;84:23f15028. PubMedAbstract available
July 2023
ANDRADE C Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease
and Parkinson Disease: Questionably Significant Benefits.
J Clin Psychiatry. 2023;84:23f15009. PubMedAbstract available
March 2023
BURKE AD, Goldfarb D Diagnosing and Treating Alzheimer Disease During the Early Stage.
J Clin Psychiatry. 2023;84:LI21019AH3C. PubMedAbstract available
LENZE EJ, Reiersen AM, Zorumski CF, Santosh PJ, et al Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's
Disease, and Cancer.
J Clin Psychiatry. 2023;84:22r14494. PubMedAbstract available